• Hereditary Cancer Syndromes - Comprehensive Panel includes 176 Gene(s)

• Basal Cell Nevus Syndrome (Gorlin-Syndrome) includes 3 Gene(s)

• Hereditary Leukemia includes 17 Gene(s)

• Lung cancer includes 9 Gene(s)

• Malignant melanoma includes 16 Gene(s)

• Neuroblastoma includes 15 Gene(s)

• Neurofibromatosis / Schwannomatosis includes 5 Gene(s)

• PreCan includes 70 Gene(s)

• PreCan+ includes 70 Gene(s)

• Tuberous sclerosis includes 2 Gene(s)

• EGFR activating variants in exons 18-21 for personalized therapy management includes 1 Gene(s)

• PI3K inhibitors includes 1 Gene(s)

• Personalized therapy management, breast cancer includes 8 Gene(s)

• Personalized therapy management Cholangiocarcinoma includes 1 Gene(s)

• Personalized therapy management, Colorectal cancer includes 4 Gene(s)

• Personalized therapy management, breast cancer (Hotspot-regions in 6 Genes) includes 6 Gene(s)

• Personalized therapy management, Colorectal cancer includes 4 Gene(s)

• ESR1 Multiplex-hotspot-regions includes 1 Gene(s)

• personalized therapy management, NSCLC includes 4 Gene(s)

• Personalized therapy management, NSCLC includes 13 Gene(s)

• Guardant360CDx, pan-cancer liquid biopsy - therapy-relevant variants including MSI and gene fusions includes 74 Gene(s)

• PARP inhibitor indication includes 2 Gene(s)

• Personalized therapy management, Prostate cancer includes 5 Gene(s)

• Personalized therapy management Thyroid cancer includes 2 Gene(s)

• Pan-Tumor Profiling, personalized therapy management includes 27 Gene(s)

• Personalized therapy management, Urothelial cancers includes 4 Gene(s)